Patrick CallaghanAssociateMcDermott Will & Emery Websitewww.mwe.comOrganization ProfileFull ProfileBlogwww.mwe.com/insightsConnectEmailTwitterLinkedIn312 984 3641 Professional Biography Patrick Callaghan is an associate in the law firm of McDermott Will & Emery LLP and is based in the Firm’s Chicago office. He focuses his practice on health law matters. More Legal and Business Bylines From Patrick Callaghan CMS Final Rule Overhauls Long-Term Care Facility Regulations & Federal Court Blocks Enforcement of Key Provision - (Posted On Friday, December 16, 2016) Ninth Circuit Considers Limits to DEA Access to Oregon Prescription Drug Monitoring Program - (Posted On Monday, November 14, 2016) CMS Increase in Mandated Nursing Facility Civil Monetary Penalties - (Posted On Tuesday, September 13, 2016) Office for Civil Rights (OCR) to Begin Phase 2 of HIPAA Audit Program - (Posted On Tuesday, July 29, 2014) Current Legal Analysis Get the F*** Off My Site! Court Upholds Verbal Contract Termination by: John Mark Goodman Differing Approaches to Earned Wage Access Programs Lead to Regulatory Conflict by: Susan Gross Sholinsky Jury Sides with Penn State in Vintage Trademark Case by: Sara M. Bauer The 2025 Final Hospital Outpatient Prospective Payment System and Physician Fee Schedule Rules: What Pharma Stakeholders Need to Know by: Stephanie Trunk , Shoshana Golden Balancing the Scales: How to Use “Legitimate Interest” to Process Personal Data “Fairly” by: Charles-Albert Helleputte , Claire Murphy Senate Judiciary Subcommittee Holds Back Two Key Patent Reform Bills by: Christopher M. Bruno Upcoming Events Dec 10 2024 Legal AI Week 2024 Nov 21 2024 Third-Party Litigation Funding through a Transatlantic Lens Nov 21 2024 CC&Rs and Easements for Mixed-Use Projects: Best Practices for Developers Nov 21 2024 AI Patent Eligibility: Processing the USPTO's New Guidance Nov 21 2024 Update of 2024 California Employment Law Cases Nov 25 2024 2024 Election: Impact on the Health Care Legal and Policy Landscape Webinar Dec 4 2024 TSCA 30/30 - December 4, 2024 Dec 4 2024 GLP-1 Drugs: What's Next after FDA's Resolution of Drug Shortages Print
